When a brand develops its first cosmetic product, the Cosmetic Product Safety Report (CPSR) is often regarded as little more than a regulatory requirement to fulfil before placing the product on the market. For many entrepreneurs, it is simply a document to obtain once the formulation has been finalised, testing has been completed and the packaging approved.
However, this perception reflects only part of the CPSR’s role.
The Cosmetic Product Safety Report (CPSR) does far more than demonstrate that a product is safe for consumers. As a cornerstone of a brand’s regulatory strategy, it helps facilitate market access, document regulatory compliance, reduce regulatory and financial risks, and strengthen a brand’s credibility with distributors. It also demonstrates that the product has been developed using a rigorous scientific approach in accordance with the requirements of Regulation (EC) No. 1223/2009.
In practice, the CPSR does more than help ensure consumer safety. It also supports the product’s regulatory compliance and, consequently, helping to protect both the brand and the investment behind it.
Cosmetic CPSR: A safety report central to Regulatory Compliance
The Cosmetic Product Safety Report (CPSR) is a requirement under Regulation (EC) No. 1223/2009 for all cosmetic products placed on the European Union market. It is also required, with certain adaptations, in other markets such as the United Kingdom and several ASEAN countries.
Its purpose is to demonstrate, on the basis of scientific evidence, that cosmetic product is safe under normal or reasonably foreseeable conditions of use.
Contrary to popular belief, the CPSR is not simply an administrative document. It is the result of a comprehensive scientific safety assessment carried out by a qualified Safety Assessor, who reviews all the information required to determine whether the product can be placed on the market without posing a risk to consumer health.
This assessment is based, among other things, on the formulation, the characteristics of the raw materials, the available toxicological data, the results of the relevant tests, the intended conditions of use and packaging information.
In other words, the CPSR brings together all the work carried out throughout the product development process.
Consumer safety at the core of the CPSR
The primary purpose of the Cosmetic Product Safety Report (CPSR) is to ensure that a product does not pose a risk to human health when used under normal or reasonably foreseeable conditions of use.
Each ingredient is assessed against several criteria, including its concentration, toxicological profile, intended use, frequency of application, area of application and the consumer’s potential exposure.
The objective is not simply to verify that the raw materials are permitted under cosmetic legislation.
Instead, the Safety Assessor seeks to answer one fundamental question:
Is the finished product safe under its intended conditions of use?
This distinction is fundamental.
Two products containing the same ingredients may lead to different safety conclusions if their concentrations, method of application or target population differ.
A lip balm, a face cream and a shampoo may contain several of the same ingredients while having entirely different exposure profiles.
For this reason, the CPSR never evaluates a formulation in isolation. It always assesses the product in the context of its intended use.
How the cosmetic CPSR strengthens your brand’s regulatory compliance
The Responsible Person, as designated under Regulation (EC) No. 1223/2009, is responsible for placing a cosmetic product on the market.
That responsibility continues long after the product has been placed on the market.
In the event of an inspection by the competent authorities, a consumer complaint or a reported undesirable effect, the CPSR is one of the first documents to be reviewed.
It demonstrates that the product’s safety has been assessed using a recognised scientific methodology and that the conclusions reached are supported by objective evidence.
Conversely, incomplete, inconsistent or insufficiently documented regulatory documentation may weaken the brand’s regulatory position.
Beyond protecting consumers, the CPSR also helps safeguard the business itself. It demonstrates that the product has been developed in accordance with applicable regulatory requirements through a rigorous, well documented and scientifically sound process.
How the cosmetic CPSR helps anticipate risks
In cosmetic product development, the greatest costs are often those that arise unexpectedly.
A raw material replaced late in the development process, a preservative system that fails the Preservative Efficacy Test (Challenge Test), incomplete supplier documentation, or stability testing revealing formulation instability can all significantly delay placing the product on the market.
These situations may require reformulation, additional testing, updates to the Product Information File (PIF), revision of the Cosmetic Product Safety Report (CPSR), or even amendments to the product labelling or packaging where required following changes to the formulation or regulatory information.
Integrating the requirements of the safety assessment from the earliest stages of product development helps prevent many of these issues. The selection of raw materials, the quality of supplier documentation, formulation design and test planning all contribute to reducing delays, avoiding unnecessary costs and minimising last minute changes.
From this perspective, the CPSR should not be viewed simply as a final validation step, but rather as a framework that guides the development of a compliant, well documented and scientifically substantiated cosmetic product.
The CPSR: A mark of credibility for your brand
Consumers are placing increasing importance on the safety, transparency and quality of cosmetic products.
At the same time, distributors, pharmacies, online marketplaces and commercial partners are increasing their regulatory compliance expectations.
Having a robust regulatory dossier does not guarantee that no issues will ever arise.
However, it does demonstrate that the product has been developed through a rigorous, well documented and scientifically substantiated process in compliance with the requirements of Regulation (EC) No. 1223/2009.
The CPSR reflects the quality of Cosmetic Product Development
One aspect that is rarely recognised is that the CPSR does not make a formulation safer. Its role is to assess, on the basis of the available evidence, whether the product can be considered safe under normal or reasonably foreseeable conditions of use.
The quality of this assessment depends largely on the work carried out earlier in the development process. A formulation developed using well documented raw materials, suppliers able to provide the necessary technical documentation, appropriate testing and comprehensive technical documentation provides the Safety Assessor with all the information required to reach a scientific conclusion.
Conversely, incomplete data, insufficient specifications or poorly documented technical decisions may lead to requests for additional information or even additional investigations before the safety assessment can be finalised.
In this respect, the CPSR provides a reliable indication of the quality of the scientific and regulatory work underpinning a cosmetic product.
The CPSR takes a holistic approach to product safety
A common misconception is that the safety assessment is based solely on the formulation and the concentration of its ingredients.
In reality, the CPSR considers all the information required to assess the product’s safety under normal or reasonably foreseeable conditions of use.
Depending on the nature of the product, the Safety Assessor may review, among other things:
- the qualitative and quantitative composition of the formulation;
- the specifications of the raw materials and the quality of their supporting technical documentation;
- the available toxicological data for each ingredient;
- impurities, trace substances and contaminants that may be present;
- the results of the tests performed, particularly stability testing and the Preservative Efficacy Test (Challenge Test), where applicable;
- the packaging, where it may influence the product’s safety or stability;
- the intended conditions of use, the target population and expected consumer exposure;
- the precautions for use and warnings appearing on the product label.
This comprehensive approach enables the product to be assessed as a whole rather than solely on the basis of its composition. It is this holistic perspective that makes the CPSR a genuine scientific safety assessment rather than a simple verification that a formulation complies with cosmetic legislation.
What is the difference between the CPSR and the Product Information File (PIF)?
The Cosmetic Product Safety Report (CPSR) is one of the core components of the Product Information File (PIF), as required under Regulation (EC) No. 1223/2009.
The PIF brings together all the documentation required to demonstrate that a cosmetic product complies with Regulation (EC) No. 1223/2009. It includes, among other things, a description of the cosmetic product, the Cosmetic Product Safety Report (CPSR), a description of the manufacturing method in accordance with Good Manufacturing Practice (GMP), evidence supporting the product claims, and the results of any relevant testing.
The Responsible Person must keep the PIF readily available to the competent authorities for 10 years from the date on which the last batch of the cosmetic product was placed on the market.
The CPSR is therefore a central component of the Product Information File, but it represents only one element of the broader regulatory documentation required to demonstrate the product’s safety and compliance with Regulation (EC) No. 1223/2009.
The cosmetic CPSR: An investment rather than a cost
For many brand founders, developing their first cosmetic product also means navigating a highly demanding regulatory environment. The CPSR is therefore often perceived as an additional administrative requirement or an unavoidable cost, whereas it is, in reality, an essential step in placing a cosmetic product on the market.
It should instead be regarded as a strategic investment.
A product launch delayed by several weeks can result in costs that far exceed those associated with carrying out a safety assessment under the right conditions.
Every reformulation, additional test and regulatory correction requires additional time, resources and costs.
Conversely, when a laboratory integrates the requirements of the safety assessment from the earliest stages of product development, it becomes much easier to identify and address the technical and regulatory constraints that may affect the product launch timeline.
When regulation supports iinnovation in cosmetics
The Cosmetic Product Safety Report (CPSR) is often described simply as a regulatory requirement that must be prepared before a cosmetic product can be placed on the market. While this is true, it does not fully reflect its importance.
Beyond assessing consumer safety, the CPSR is part of a broader product development strategy, in which every technical, regulatory and documentation decision contributes to the product’s final compliance. The earlier these requirements are considered, the more efficiently the development process can be managed, reducing the risk of delays, reformulations or requests for additional information.
This is why choosing the right laboratory is a critical decision. A cosmetic manufacturing laboratory that integrates Regulatory Affairs within its Research & Development (R&D) department can anticipate the requirements that will ultimately form part of the CPSR assessment from the earliest stages of development. This close collaboration between formulation scientists, regulatory specialists and quality teams helps guide formulation decisions, select raw materials supported by appropriate technical documentation, and build a robust technical dossier throughout the project.
At Laboratoire Orescience, this approach is an integral part of how we develop cosmetic products. Our R&D and Regulatory Affairs teams work in close collaboration to support every brand in developing innovative cosmetic products that comply with the requirements of Regulation (EC) No. 1223/2009 and are ready for market placement under optimal regulatory conditions.
Beyond European regulatory compliance, our Regulatory Affairs Department also supports brands in their regulatory projects across France and international markets, helping them comply with the regulatory requirements applicable in their target markets, including the European Union, the United Kingdom, the United States, Asia and the Middle East.
